Skip to content

Comparison of Pulmonary Function, Exercise Capacity, and Physical Activity Level Between Children With Hemophilia and Healthy Controls

Comparison of Pulmonary Function, Exercise Capacity, and Physical Activity Level Between Children With Hemophilia and Healthy Controls

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06636565
Enrollment
34
Registered
2024-10-10
Start date
2024-07-25
Completion date
2025-07-25
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Children, Hemophilia

Keywords

Hemophilia, Exercise capacity, Pulmonary function

Brief summary

Hemophilia is a rare X-linked congenital bleeding disorder characterized by deficiency of clotting factor VIII (hemophilia A) or deficiency of factor IX (hemophilia B) with complex diagnosis and management. Participation in physical activity is still limited in children with hemophilia, probably due to protective attitudes of families/patients and avoidance of activity, and possibly also as a result of chronic pain. Exercise capacity has been identified as a protective factor against joint problems in hemophilia. Aerobic fitness is associated with better pulmonary function in children. Chronic pain and decreased range of motion due to recurrent bleeding in joints and muscles in hemophilia may indirectly affect posture and respiratory mechanics, leading to impaired pulmonary function. This study aims to compare pulmonary function, exercise capacity, posture, and physical activity level between children with hemophilia and healthy controls and to investigate the relationship between these parameters.

Interventions

OTHERNo intervention

No intervention

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

Hemophilia group Inclusion criteria: * Having been diagnosed with hemophilia and being clinically stable, * Being between the ages of 8-18, * Being on prophylaxis treatment (a routine treatment), * Being 125 cm or taller, * Being inhibitor negative at the time of enrollment, * To be able to cooperate with the tests to be performed, * Being willing to participate in the study.

Exclusion criteria

* Being inhibitor positive at the time of enrollment, * Having a history of acute joint bleeding, * Being unable to bear weight on the extremities, * Having a history of acute intramuscular bleeding, * Having undergone radionuclide synovectomy, * Having a history of surgery on any of the lower extremity joints, * Having a severe cardiovascular, orthopedic or neurological problem that may affect the assessments. Control group Inclusion criteria: * Not having any known internal or chronic disease * Being male between the ages of 8-18 * Having full range of motion in the upper extremity * Having full range of motion in the lower extremity * Not having any history of injury or surgery in the lower extremity * Being 125 cm or taller * Being willing to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Forced vital capacity1st dayPulmonary function test using a spirometer will be performed. Forced vital capacity will be recorded.
Forced expiratory volume in one second1st dayPulmonary function test using a spirometer will be performed. Forced expiratory volume in one second will be recorded.
Forced expiratory volume in one second/forced vital capacity ratio1st dayPulmonary function test using a spirometer will be performed. Forced expiratory volume in one second/forced vital capacity ratio will be recorded.
Peak expiratory flow1st dayPulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded. will be recorded.
Forced mid-expiratory flow (FEF25-75)1st dayPulmonary function test using a spirometer will be performed. Forced mid-expiratory flow (FEF25-75) will be recorded. will be recorded.
Hemophilia Joint Health Score1st dayHemophilia Joint Health Score is a scoring used by physiotherapists in hemophilia treatment centers to detect early hemophilic arthropathy symptoms and to monitor joint health. HJHS consists of edema (0-3), duration of edema (0-1), muscle atrophy (0-2), crepitus during movement (0-2), loss of flexion (0-3), loss of extension (0-3), joint pain (0-2) and evaluation of muscle strength of knees, ankles and elbows (0-4) and global gait score (0-4). The maximum score is 124, with higher scores indicating worse joint health.
Corbin Posture Rating Scale1st dayCorbin Posture Rating Scale and observational posture analysis. It is an assessment consisting of lateral and posterior posture analysis. '0' is excellent, 12 and above indicates poor posture.
Exercise capacity1st dayTo assess exercise capacity, a symptom-limited cardiopulmonary exercise test will be performed on a bicycle ergometer using Godfrey protocol. Cardiopulmonary responses and effort perceptions will be recorded. In Godfrey protocol, workload increases are adjusted according to height: workload is increased by 10 W/min for \< 125 cm, by 15 W/min for 125-150 cm and by 20 W/min for \>150 cm.
Physical activity level1st dayThe Physical Activity Questionnaire for Children (PAQ-C) and the Physical Activity Questionnaire for Adolescents (PAQ-A) will be used to assess physical activity levels. The Turkish versions of these assessment tools have been shown to be valid and reliable.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026